Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,711,455,722
+$883,218,155 QoQ
Shares Held
14,749,069
+13.4% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#17
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. ABBV ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,711,455,722 | 14,749,069 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,828,237,567 | 13,003,989 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,245,231,393 | 9,826,388 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,454,839,638 | 10,602,227 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,681,723,139 | 9,060,032 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,507,457,428 | 7,194,814 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,811,513,959 | 10,194,226 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,025,742,335 | 10,257,962 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,876,979,035 | 10,943,208 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,956,516,998 | 10,744,190 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,464,929,705 | 9,452,989 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,910,139,505 | 12,814,568 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,773,681,916 | 13,164,714 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,801,067,994 | 17,575,880 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,300,577,189 | 20,423,100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,291,008,503 | 24,521,336 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,718,522,341 | 30,807,798 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,954,645,107 | 36,732,127 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,412,132,620 | 32,585,913 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,827,059,225 | 26,208,021 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,266,485,094 | 28,999,335 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,486,003,742 | 32,212,195 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,483,276,881 | 32,508,417 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,867,686,001 | 32,739,879 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,101,840,620 | 41,778,780 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,270,671,367 | 42,927,830 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||